Comparative study of mouse induced pluripotent stem cells derived cardiomyocytes obtained from three different fibroblast sources
Abstract Background – The ability to generate induced pluripotent stem cells-derived cardiomyocytes (iPSC-CM) has raised much expectation for treatment of myocardial infarction as a stem cell based therapy. In the present study we aimed to evaluate the ability of iPSC-CM production in vitro from three fibroblast sources and verify if there is inter-clonal or inter-source variance. Methods and Res
